CCND1 and breast cancer: In any analysis examining the relevance of cyclin D1 protein in breast cancer, failing to remove the CCND1 amplified cases biases the cyclin D1 overexpressed group by artificially inflating the number of cyclin D1 “high” tumors with a worse clinical outcome.